Publications
244
Citations
3,310
Est. group size
~2
Recurring co-author estimate
Active years
17
Publishing since 2010
Jessica S. Merlin's research focuses on the intersection of chronic pain management, opioid/substance use disorder treatment, and palliative or cancer care. Her work includes developing and testing interventions to help people manage pain while safely engaging in medication treatment for opioid use disorder, studying harm reduction strategies in clinical settings, and examining barriers and stigma affecting patients with pain, cancer, or substance use disorders. Much of this research uses qualitative interviews, implementation studies, and analyses of large patient datasets like Medicare and national survey data.
Publication output grew steadily from 2017 through a peak around 2023, followed by a modest decline in 2024-2025 (with 2026 data still incomplete).
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- “Whatever it is, it Works” Understanding of Buprenorphine/Naloxone and Sources of Information: A Qualitative Study Among People Who Use Fentanyl and Clinicians
Journal of Addiction Medicine · 2026
- Perspectives on Harm Reduction Kit Implementation in Heterogeneous Outpatient Clinics
Research Square · 2026
- Tailoring of a chronic pain self-management intervention for individuals with opioid use disorder in office-based addiction treatment
Journal of Substance Use and Addiction Treatment · 2026
- Study Protocol for a Pain Self-Management Intervention to Reduce Pain and Improve MOUD Engagement in Primary Care: A Randomized Trial
Substance Use & Addiction Journal · 2026
- A Buprenorphine Pocket Card and Tool Kit Tailored to Palliative Care Clinicians: An Education and Implementation Cohort Study
Journal of Palliative Medicine · 2026
- Research recommendations for the HEAL Initiative: A path forward for pain research
Journal of Pain · 2026
- “A lot of bureaucracy”: Structural barriers to prescription opioids in cancer pain management
Journal of Pain · 2026
- Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer
JNCI Journal of the National Cancer Institute · 2025
- Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl
Addiction Science & Clinical Practice · 2025
- The 3P‐CP model: Expanding our conceptualization of cancer pain
Cancer · 2025
- Patient Perceptions of the Palliative Recovery Engagement Program (P-REP) Clinic, a Novel Outpatient Model for Patients With Advanced Illness and Substance Misuse
American Journal of Hospice and Palliative Medicine® · 2025
- The Illusion of Choice—Buprenorphine Without Implementation
JAMA Internal Medicine · 2025
- Micro-costing analysis of harm reduction services in office-based addiction treatment
Drug and Alcohol Dependence · 2025
- Association of Pharmacologic and Nonpharmacologic Management of Acute Low Back Pain with Overdose Hospitalizations: A Nested Case-Control Study
Journal of Integrative and Complementary Medicine · 2025
- “To not feel fake, it can’t be fake”: co-creation of a harm reduction, peer-delivered, health-system intervention for people who use drugs
Harm Reduction Journal · 2025
- Journal of Pain and Symptom Management×25
- Journal of Pain×16
- JAIDS Journal of Acquired Immune Deficiency Syndromes×10
- Journal of Palliative Medicine×9
- Journal of General Internal Medicine×8
- Jennifer F. Waljee
Medicine · Indiana University
- Lisa Mostafavifar
Medicine · The Ohio State University
- Eric C. Strain
Medicine · The Ohio State University
- Edward W. Boyer
Medicine · The Ohio State University
- Michael A. Bushey
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile